The Predictive Value of Vessels Encapsulating Tumor Clusters in Treatment Optimization for Recurrent Early-stage Hepatocellular Carcinoma

Zhiyuan Chen(Wuhan University), Rongping Guo(Sun Yat-sen University), Shaohua Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhixing Guo(Sun Yat-sen University), Wen‐Ping Lin(Sun Yat-sen University), Lianghe Lu(Sun Yat-sen University), Jie Mei(Sun Yat-sen University), Wei Wei(Zhujiang Hospital)

Research Square

February 26, 2021

10.21203/rs.3.rs-228188/v1

Cited by 0

Related Papers

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion

|JAMA Oncology|2019|559

Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial

|Journal of Clinical Oncology|2020|217

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma

|Therapeutic Advances in Medical Oncology|2021|216

Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

|癌症：英文版|2018|189

A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome

|European Journal of Endocrinology|2011|160